U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday.
The Dow traded down 0.07% to 32,877.52 while the NASDAQ rose 0.27% to 12,045.02. The S&P also rose, gaining, 0.23% to 4,118.09.
Also check this: Home Depot And 2 Other Stocks Insiders Are Buying
Leading and Lagging Sectors
Communication services shares jumped by 0.9% on Monday. Meanwhile, top gainers in the sector included The Arena Group Holdings, Inc. (NYSE:AREN), up 29% and Kanzhun Limited (NASDAQ:BZ) up 20%.
In trading on Monday, energy shares fell 0.2%.
Top Headline
Science Applications International Corporation (NYSE:SAIC) reported upbeat results for its first quarter.
Science Applications posted quarterly earnings of $1.88 per share, beating analysts’ estimates of $1.77 per share. The company’s quarterly sales came in at $2.00 billion, versus expectations of $1.93 billion.
Science Applications raised its FY23 EPS guidance from $6.80-$7.10 to $6.90-$7.20 and narrowed its FY23 sales guidance from $7.35 billion-$7.55 billion to $7.43 billion-$7.55 billion.
Equities Trading UP
DiDi Global Inc. (NYSE:DIDI) shares shot up 38% to $2.56 after the Chinese government said the company can resume adding new users.
Shares of Futu Holdings Limited (NASDAQ:FUTU) got a boost, shooting 19% to $43.91 after the company reported Q1 earnings results.
Yumanity Therapeutics, Inc. (NASDAQ:YMTX) shares were also up, gaining 39% to $1.9708 after the company announced definitive agreements for two strategic transactions. Yumanity Therapeutics agreed to sell its lead clinical-stage product candidate, YTX-7739, and discovery-stage neuroscience candidates to Janssen Pharmaceutica NV, a unit of Johnson & Johnson for $26 million. Under the second agreement, Kineta will become a wholly-owned subsidiary of Yumanity in an all-stock transaction, resulting in a combined publicly-traded company renamed Kineta Inc.
Equities Trading DOWN
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) shares tumbled 76% to $2.0697 after the company announced the PRAX-114 Phase 2/3 monotherapy Aria study did not achieve statistical significance on the primary endpoint.
Shares of Gevo, Inc. (NASDAQ:GEVO) were down 33% to $3.0417 after the company announced a $150 million registered direct offering priced at-the-market under Nasdaq rules.
Pear Therapeutics, Inc. (NASDAQ:PEAR) was down, falling 27% to $3.15. Pear Therapeutics announced new analysis showing reduction in healthcare resource utilization and associated costs in patients using reSET at 6 months.
Also check out: Executives Sell Around $325M Of 3 Stocks
Commodities
In commodity news, oil traded down 0.2% to $118.64, while gold traded down 0.3% to $1,844.70.
Silver traded up 1% to $22.125 on Monday while copper fell 0.8% to $4.4345.
Euro zone
European shares were higher today. The eurozone’s STOXX 600 gained 0.92%, London’s FTSE 100 gained 1% while Spain’s IBEX 35 Index rose 1.28%. The German DAX gained 1.34%, French CAC 40 rose 0.98% and Italy’s FTSE MIB Index jumped 1.65%.
Economics
There were no major US economic releases Monday
Check out this: NVIDIA And 4 Other Stocks Insiders Are Selling
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 86,522,560 cases with around 1,033,590 deaths. India confirmed a total of at least 43,181,330 cases and 524,700 deaths, while Brazil reported over 31,153,760 COVID-19 cases with 667,050 deaths. In total, there were at least 535,513,050 cases of COVID-19 worldwide with more than 6,320,680 deaths.
